Use of piperazine derivatives for the manufacture of drugs for the treatment of fear or fear syndromes

摘要

It has been found that a group of piperazine derivatives known to have blood-pressure lowering properties possess good anxiolytic properties. In two well known animal test models the compounds are active when used intraperitoneally in dosages of 0.3 mg/kg.